Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-21-000049
Filing Date
2021-05-12
Accepted
2021-05-12 16:02:07
Documents
47
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20210331.htm   iXBRL 10-Q 626085
2 EX-31.1 slrx20210331ex-311.htm EX-31.1 9028
3 EX-31.2 slrx20210331ex-312.htm EX-31.2 8825
4 EX-32.1 slrx20210331ex-321.htm EX-32.1 6441
  Complete submission text file 0001615219-21-000049.txt   3208923

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20210331.xsd EX-101.SCH 21898
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20210331_cal.xml EX-101.CAL 37519
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20210331_def.xml EX-101.DEF 95451
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20210331_lab.xml EX-101.LAB 350223
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20210331_pre.xml EX-101.PRE 208040
10 EXTRACTED XBRL INSTANCE DOCUMENT flks-20210331_htm.xml XML 408054
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 21914990
SIC: 2834 Pharmaceutical Preparations